Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
" I have noted the ceo of AstraZeneca talking up the sp saying that a vaccine is imminent. He’s said it twice over the last month or so. Probably his dog has bought shares the day before."
or angling for a pay rise, given he claims to be the lowest paid CEO in eu/us pharma circles
Well said crystalballbroke, there’s one thing I’ve learnt which isn’t much, is that never ever trust brokers or directors. Alls they want is your money. They are not your friends . I have noted the ceo of AstraZeneca talking up the sp saying that a vaccine is imminent. He’s said it twice over the last month or so. Probably his dog has bought shares the day before.
There may well be a vaccine made that works but to keep saying it without knowing it’s going to work by the ceo is not on. Now having said that I will buy AstraZeneca on any good drop.
we saw practically nothing from that deal, any profit vanished because the weak willed BOD took their pound of flesh in the deal and positions here to leave shortly after with golden handshakes, and the low ball offer at the time they accepted/recommended, was over 50% paid in useless shares here valued at least £2 over their true value, which by the time we got them were over £2 lower each than what we should have gotten if this scheming group had paid for what it bought, instead of just printing some more shares.
I've been stuck in this POS since then, because i want what was promised and owed to me
Those would be the quantum shareholders that had seen their share price sink to 50p and accepted 80p partly in cash part shares. Overpaying for an acquisition is always a risk and often happens.
Quantum shareholders still in profit if you think of 50p as the value of each share.
i'd take 11.25 - this POS has never been worth that, last time thy pumped it that high was to F over quantum pharma share holders
I would rather it go on to bigger things than be sold
Yeah, adjusted EPS is looking likely to come in around 75p for the full year, so at 15x PE (which is a tad lower than they've historically been), that gives £11.25... but that's not exactly a knockout bid - I'd expect them to pay around 18x, which is £13.50... but it's old news, so may not happen. Let's just see what FY19 results bring
But the lack of SP movement indicates a lack of belief in any bidder emerging.
£14 is into knock out bid territory. Hard for the Board to refuse to consider a bid at such a level.
10-11 is too cheap
Advent must be trying to get them on the cheap. They can have mine for 14 quid.
Clinigen are looking at £14/£15 per share to sell
Added a few 100 shares this morning in anticipation of a decent trading update and speculative cover on a bid, although I consider this a bonus if it happens.
Had s good look around various sites this am but couldn’t find anything . Maybe something is happening at boardroom level?
Why no RNS this morning? My broker emailed a corporate action notice saying Advent were interested last night in CLIN which I hold in their account. The message was from CLIN themselves. Should I presume this website is slow again?
Something is coming for the good
Anyone wishing to read the news report it can be found via the This is Money.co.uk website